What we do HVAX Technologies Ltd specializes in turnkey HVAC projects, cleanrooms, and engineering consultancy primarily for pharmaceuticals and healthcare sectors in India and globally. |
Founded in 2,010 |
Market share Recognized trusted partner for mission-critical pharmaceutical and healthcare infrastructure worldwide with expanding international presence. |
Problem solved Provides end-to-end solutions including design, procurement, and management for controlled environment and cleanroom infrastructure addressing critical pharma and healthcare needs. |
Top clients or who we serve Pharmaceutical, healthcare, hospital, and biotech sectors; serving B2B clients across India, Asia, Africa, and the Middle East. |
Key management Nirbhaynarayan Singh (Chairman & Whole-time Director), Prayagdatt Mishra (Managing Director) with strong industry experience. |
Our journey and innovations Founded in 2010, expanded from HVAC contracting to turnkey pharma projects; first overseas project in 2012; listed in 2024; entered Algeria and Iraq in FY25. |
Where we operate India, Kenya, Algeria, Iraq, and Middle East with projects across Asia, Africa, and international markets. |
Top products or what we offer Turnkey HVAC and cleanroom solutions, engineering consultancy, GAP analysis, validation, and containment consultancy for pharma and healthcare clients. |
Top brands HVAX turnkey HVAC projects, specialized engineering consultancy services; known for high-quality, regulated environment infrastructure. |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue driven by project-based turnkey contracts; growth also supported by consultancy services with recurring engagements. |
Our industry position Leading niche player in specialized HVAC and cleanroom turnkey projects for pharma and healthcare, expanding with international footprints. |
Financial highlights FY 2024-25 revenue ₹131.03 crores; net profit ₹11.04 crores; revenue growth 23.54%; profit growth 29.69% year-on-year. |
Geographical revenue split Indian operations contribute ~16.5% revenue; foreign operations ~83.5%, highlighting strong international project focus. |
Order book - |
Whats driving growth Growing pharma and healthcare infrastructure demand, international market expansion, and specialized engineering expertise. |
Our future plans Expansion in international markets including Algeria and Iraq; enhancing turnkey solutions and consultancy offerings. |
Our green promise - |
Our people and values Committed to employee welfare, ethical practices, diversity, and a safe working environment; fosters strong employee relations. |
Key challenges ahead Managing cross-border project risks, regulatory compliance, and maintaining high-quality standards amid global expansion. |
Interesting facts Converted from private to public company in 2024; raised ₹33.52 crores via IPO; completed projects across 3 continents. |
Risks and strategy Identifies risks via Board oversight; focuses on compliance, quality control, and client satisfaction to mitigate challenges. |
